Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-21
1996-08-13
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548958, A61K 31635, C07D49156
Patent
active
055456596
ABSTRACT:
Novel 1-(2-,3- or 4-hydroxylaminobenzensulfonyl-1a,2,6,6 a-tetrahydro-1H,4H-[1,3]-dioxepino[5,6-b]azirines with hypoglycemic activity are prepared by selective reduction of appropriate 1-(2-,3- or 4-nitrobenzenesulfonyl) derivatives.
REFERENCES:
patent: 3694509 (1972-09-01), Rylander et al.
patent: 3715397 (1973-02-01), Rylander et al.
patent: 3927101 (1975-12-01), Le Leduc
patent: 4723030 (1988-02-01), Davis
patent: 5166435 (1992-11-01), Sharma et al.
patent: 5266173 (1993-11-01), Bandlish et al.
patent: 5286744 (1994-02-01), Dumic et al.
Dumic et al, "1-Sulfonyl-1a,2,6,6a-tetrahydro, etc" Tet. Let. 34 (22) pp. 3639-3642 (1993).
Dumi c Miljenko
E skinja Mirela
Fili c Darko
Jamnicky Blanka
Vinkovi c Mladen
Morris Patricia L.
PLIVA farmaceutska, kemijska, prehrambena i kozmeticka industrij
LandOfFree
Hydroxylamines with hypoglycemic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxylamines with hypoglycemic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxylamines with hypoglycemic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1048181